ArticlesRegulatory August 8, 2024 Address the complexity of protein characterization Since the FDA approved the first monoclonal based therapy in 1985, mAbs have had significant… Ross Burns
ArticlesBioPharmaRegulatory March 14, 2019 Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars Biotherapeutics are an emerging class of treatment modalities that are manufactured... admin-element
ArticlesDownstream March 1, 2018 Impurity Testing of Biologic Drug Products Experts share insights on the various methods used for purity and impurity analysis of therapeutic... admin-element